Phase 2 Study of Tafasitamab with Lenalidomide and Rituximab for Untreated Follicular and Marginal Zone Lymphoma | Clinical Trial

Phase 2 Study of Tafasitamab with Lenalidomide and Rituximab for Untreated Follicular and Marginal Zone Lymphoma | Clinical Trial | Right2Hope